Cabaletta Bio Inc (CABA)

08:31 AM

Enterprise value to EBIT forward of Cabaletta Bio, Inc. – NASDAQ:CABA - TradingView

08:31 AM

Jul 06, 2026

CABA Stock On Track For Best Day In 6 Months After Positive Early Results From Cell Therapy Trial - Stocktwits

Jul 06, 2026

Jul 04, 2026

CABA Stock Draws Scrutiny As Ownership Filings Shift - timothysykes.com

Jul 04, 2026

Jul 03, 2026

Certain Common Stock of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 4-JUL-2026. - marketscreener.com

Jul 03, 2026

Jul 03, 2026

Cabaletta Bio (CABA) Stock Forecast & Analyst Ratings - Moomoo

Jul 03, 2026

Jun 30, 2026

Cabaletta Bio(CABA) Stock Options Chain | Quotes & News - Moomoo

Jun 30, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS:CABA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell Small Cap Completeness Index - marketscreener.com

Jun 28, 2026

Jun 28, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to Russell 2500 Index - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Cabaletta Bio: The Market Sold The EULAR News, I'm Buying (NASDAQ:CABA) - Seeking Alpha

Jun 26, 2026

Jun 26, 2026

Cabaletta Bio, Inc. Actuals & Estimates (NASDAQ:CABA) - TradingView

Jun 26, 2026

Jun 25, 2026

CABA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

CABACabaletta Bio Inc Volatility & Greeks - Finviz

Jun 25, 2026

Jun 23, 2026

Cabaletta Bio (CABA) upgraded to buy: Here's why - MSN

Jun 23, 2026

Jun 21, 2026

Cabaletta Bio, Inc.(NasdaqGS: CABA) added to S&P Biotechnology Select Industry Index - marketscreener.com

Jun 21, 2026

Jun 17, 2026

Cabaletta Bio Inc (CABA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Cabaletta Bio Inc (CABA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Cabaletta Bio Inc (CABA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup - Insider Monkey

Jun 17, 2026

Jun 17, 2026

CABA Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 17, 2026

Jun 16, 2026

5 Small Cap Stocks with Potential to Rise 1000 Percent - Insider Monkey

Jun 16, 2026

Jun 12, 2026

Cabaletta Bio Shareholders Approve Share Increase and Directors - The Globe and Mail

Jun 12, 2026

Jun 11, 2026

Cabaletta Bio (NASDAQ: CABA) doubles authorized common shares - Stock Titan

Jun 11, 2026

Jun 10, 2026

[Form 4] Cabaletta Bio, Inc. Insider Trading Activity - Stock Titan

Jun 10, 2026

Jun 10, 2026

Director at Cabaletta Bio (CABA) receives grant of 22,000 stock options - Stock Titan

Jun 10, 2026

Jun 10, 2026

Cabaletta Bio (CABA) director receives stock options for 22,000 shares at $3.22 - Stock Titan

Jun 10, 2026

Jun 10, 2026

Cabaletta Bio | 4: Statement of changes in beneficial ownership of securities-Director Bollard Catherine - Moomoo

Jun 10, 2026

Jun 10, 2026

Cabaletta Bio (CABA) director Catherine Bollard receives 22,000 stock options at $3.22 - Stock Titan

Jun 10, 2026

Jun 10, 2026

22,000 options granted to Cabaletta Bio (CABA) director Brun - Stock Titan

Jun 10, 2026

Jun 09, 2026

Cathie Wood's ARK Invest Joins Cellares' $277 Million Series D - Business Wire

Jun 09, 2026

Jun 08, 2026

CABA: Rese-cel delivers durable, safe remissions in myositis, supporting rapid outpatient adoption - TradingView

Jun 08, 2026

Jun 08, 2026

CABA: Rese-cel shows durable, safe, drug-free responses, enabling rapid outpatient adoption and expansion - TradingView

Jun 08, 2026

Jun 08, 2026

Cabaletta Bio Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus

Jun 08, 2026

Jun 07, 2026

Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases - Yahoo Finance

Jun 07, 2026

Jun 06, 2026

Jennison Associates LLC Increases Stake in Cabaletta Bio Inc - GuruFocus

Jun 06, 2026

Jun 05, 2026

Investors’ Stock Portfolio: Top 5 Penny Stocks To Buy - Insider Monkey

Jun 05, 2026

Jun 05, 2026

Prudential (NYSE: PRU) holds 24.3M shares of Cabaletta Bio (CABA), 11.4% - Stock Titan

Jun 05, 2026

Jun 04, 2026

Jennison Associates (NASDAQ: CABA) holds 24.27M shares, 11.4% - Stock Titan

Jun 04, 2026

Jun 04, 2026

Morgan Stanley Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Jun 04, 2026

Jun 04, 2026

Cabaletta Bio reports phase 1/2 data for autoimmune therapy - Investing.com UK

Jun 04, 2026

Jun 04, 2026

Jefferies reiterates Cabaletta Bio stock rating on autoimmune data By Investing.com - Investing.com South Africa

Jun 04, 2026

Jun 03, 2026

CABA: Cabaletta Bio Shares Positive Clinical Updates at EULAR 20 - GuruFocus

Jun 03, 2026

Jun 03, 2026

H.C. Wainwright Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $16 - Moomoo

Jun 03, 2026

Jun 03, 2026

Cabaletta Bio Highlights Rese-cel Data and Pivotal Path - TipRanks

Jun 03, 2026

Jun 03, 2026

Jefferies reiterates Cabaletta Bio stock rating on autoimmune data - Investing.com

Jun 03, 2026